Atlas Trials

Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets

Clinical trial NCT03791125 · UNKNOWN

Trial details

NCT number
NCT03791125
Sponsor
Peking University First Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Neuropathy of Diabetes
Start date
2018-11-20
Primary completion
2019-03-20
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.